|
| | 10300SB1344sam001 | - 2 - | LRB103 28584 SPS 58485 a |
|
|
1 | | pre-exposure prophylaxis or post-exposure prophylaxis. If a |
2 | | patient's HIV test results are reactive, the pharmacist shall |
3 | | refer the patient to an appropriate health care professional |
4 | | or clinic. If the patient's HIV test results are nonreactive, |
5 | | the pharmacist may initiate human immunodeficiency virus |
6 | | pre-exposure prophylaxis or post-exposure prophylaxis to |
7 | | eligible patients. |
8 | | The standing order must be consistent with the current |
9 | | version of the guidelines of the Centers for Disease Control |
10 | | and Prevention, guidelines of the United States Preventive |
11 | | Services Task Force, or generally recognized evidence-based |
12 | | clinical guidelines. |
13 | | A pharmacist must communicate the services provided under |
14 | | this Section to the patient and the patient's primary health |
15 | | care provider or other health care professional or clinic, if |
16 | | known. If there is no primary health care provider provided by |
17 | | the patient, then the pharmacist shall give the patient a list |
18 | | of primary health care providers, other health care |
19 | | professionals, and clinics in the area. |
20 | | The services provided under this Section shall be |
21 | | appropriately documented and retained in a confidential manner |
22 | | consistent with State HIV confidentiality requirements. |
23 | | The services provided under this Section shall take place |
24 | | in a private manner. |
25 | | A pharmacist shall complete an educational training |
26 | | program accredited by the Accreditation Council for Pharmacy |
|
| | 10300SB1344sam001 | - 3 - | LRB103 28584 SPS 58485 a |
|
|
1 | | Education and approved by the Department that is related to |
2 | | the initiation, dispensing, or administration of drugs, |
3 | | laboratory tests, assessments, referrals, and consultations |
4 | | for human immunodeficiency virus pre-exposure prophylaxis and |
5 | | human immunodeficiency virus post-exposure prophylaxis.
|
6 | | (Source: P.A. 102-1051, eff. 1-1-23 .)".
|